Stocks Health care VOGX
Health careVogenx, Inc. (VOGX)
At September 30, 2026 it held $5.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 6, 2026.
Key facts about Vogenx, Inc.
- Net worth
- Vogenx, Inc. has a market value (market cap) of $272.2M at the latest share price, and shareholders' equity of $82M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
What Vogenx, Inc. does
Vogenx, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).
Earnings: every quarter and the next report date
Latest SEC filings
What Vogenx, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026
- November 6, 2026
- October 9, 2026Executive or director change8-KVogenx appointed board member Richard Gorman as its new Chief Commercial Officer.
- September 22, 2026Executive or director change8-KVogenx appointed Ken Toombs to its Board of Directors as an independent director and Audit Committee Chair.
- September 17, 2026Quarterly report10-Q · period to June 30, 2026Vogenx reported an increased net loss for the second quarter of 2026 while raising capital through an August 2026 initial public offering.Diluted EPS -$0.07 versus -$0.05.
- September 8, 2026Passive stake (5% or more) SCHEDULE 13G
- August 19, 2026Other event 8-K
- August 13, 2026
- August 13, 2026
- August 10, 2026
Insider trades
What the people running Vogenx, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 13, 2026 | Delmar Steven RChief Financial Officer, Director | Exercised options | 4,273 | $50K |
| August 13, 2026 | Pieraccini PeterDirector | Exercised optionsindirect | 42,735 | $500K |
Who owns VOGX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| JANUS HENDERSON GROUP Ltd.13G, passive | 13% | September 8, 2026 |
Largest institutional holders
Insiders
2 insiders reported holding 747,008 shares in total, about $13.7M at the last price.
| Holder | Shares |
|---|---|
| Delmar Steven RChief Financial Officer, Director | 704,273 |
| Pieraccini PeterDirector | 42,73542,735 held indirectly |
Questions about VOGX
What does Vogenx, Inc. do?
Vogenx, Inc. is a company in the Health care sector.
What is Vogenx, Inc.'s net worth?
Vogenx, Inc. has a market value (market cap) of $272.2M at the latest share price, and shareholders' equity of $82M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
When did Vogenx, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.
Similar companies
Compare VOGX with
Follow VOGX
Get an email when Vogenx, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Vogenx, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.